The latest price situation of Repotrectinib in 2025

Repotrectinib is a targeted therapy drug for specific types of tumors. It is mainly used to treat patients with non-small cell lung cancer (NSCLC) carrying ROS1 rearrangements and NTRK fusion genes. The drug prevents the growth and spread of tumor cells by inhibiting the abnormal activities of ROS1 and NTRK, thus providing patients with a more precise treatment option.

In clinical application, repotinib has shown high efficacy, especially in patients who have received multiple therapies in the past but with poor results, and can significantly improve their progression-free survival (PFS). In addition, the use of repotinib is relatively simple, and patients can usually complete treatment on an outpatient basis, reducing the financial burden and life inconvenience caused by hospitalization. After a period of clinical observation, the safety and tolerability of repotinib have also been confirmed. Common adverse reactions include fatigue, nausea, diarrhea, etc. These side effects are usually mild and can be alleviated through symptomatic treatment.

In the Chinese market, Ripotinib has been approved and marketed by the National Medical Products Administration (NMPA), and has also been included in the National Medical Insurance List, which provides a more affordable treatment option for the majority of patients. According to current market information, the specification of Ripotinib is 40mg*120 tablets, and each box is priced at about more than 5,000 yuan. The specific price varies by region and hospital. Therefore, patients are recommended to consult the local hospital pharmacy before purchasing the drug to obtain the latest price information.

In addition to the domestic market, generic drugs of Ripotinib are also circulating in some countries and regions. For example, the price of generic drugs in Laos is relatively low, about more than 2,000 yuan. The ingredients of these generic drugs are basically the same as those of the original drugs on the domestic market, providing some patients with a more economical choice. However, when purchasing, you still need to pay attention to the quality and manufacturer of the drugs to ensure the safety of the drugs.

Reference materials:https://www.drugs.com/mtm/repotrectinib.html